NanoStilbene Recap (for those new here) Well w

NanoStilbene Recap
(for those new here)
Well what happened with NanoStilbene ?

There has been a steady move forward to the end result with this TSOI product. and it's looking promising, so i put together a mini-history of where it came from and where it's been .
start here:

The Company currently holds an issued US Patent on increasing efficacy of cancer immunotherapies using pterostilbene and nanoformulations including those utilized in the manufacture of NanoStilbene.
https://patents.google.com/patent/US9682047B2/en

and then :

NEWS 5/1/18
http://ih.advfn.com/p.php?pid=nmona&article=77309980

Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer Treatment Center
Company Aims to Leverage Transfer Factor Pulsed Autologous Dendritic Cells on StemVacs Platform with
Patented Augmenter of Cancer Immunotherapy NanoStilbene

it weaved it's way to this:

NEWS 5/15/18
http://ih.advfn.com/p.php?pid=nmona&article=77431704

Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant Nanostilbene

and this:

NEWS 7/2/18
https://ih.advfn.com/p.php?pid=nmona&article=77784227

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™
Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally Administered

a cancer pioneer of immunotherapy was recruited to accelerate StemVacs and Nanostilbene Development :

NEWS 7/23/18
https://ih.advfn.com/p.php?pid=nmona&article=77913150

Therapeutic Solutions International Recruits Internationally Recognized Cancer Immunotherapy Pioneer Dr. Francesco Marincola to Accelerate StemVacs and NanoStilbene Clinical Development
Company Focuses on Non-Toxic Therapies Using Immune System
to Selectively Kill Cancer Cells through Immunotherapy

and more Nanostilbene news :

NEWS 1/14/19
https://ih.advfn.com/stock-market/USOTC/thera...unces-prel

Therapeutic Solutions International Announces Preliminary Data for Immune Stimulation in Advanced Cancer Patients by Commercially Available Product
NanoStilbene Shown to Enhance Anticancer Immunity in Cancer Patients
through Modulation of Inflammatory Mediators

and went further :

2/19/19
Therapeutic Solutions International Continues to Refine NanoStilbene™ Formulation
NanoStilbene Shown to Reduce Tumor Necrosis Factor-a (TNF-a ) in Cancer Patients
https://ih.advfn.com/stock-market/USOTC/thera...inues-to-r

and into distribution in Mexico :

5/6/19
Therapeutic Solutions International Awards Distribution of NanoStilbene and Nano Cannabidiol in Mexico to Immun ET Laboratories, LLC.
NanoStilbene Shown to Enhance Anticancer Immunity in Cancer Patients through Modulation of Inflammatory Mediators
https://ih.advfn.com/stock-market/USOTC/thera...ds-distrib

and Nanostilbene was now mentioned more as an adjuvant then here :

7/22/19
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer
New Data Supports Development of Patented Formulation of Blueberry Extract Pterostilbene as an Adjuvant to Immuno-Oncology Treatments
https://ih.advfn.com/stock-market/USOTC/thera...rts-its-na

and more things it could be used as an adjuvant in :

7/29/19
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer
Recent Data Supports Investigation of Commercially Available Product
as an Adjuvant to Chemotherapy for Cancer
https://ih.advfn.com/stock-market/USOTC/thera...to-increas

submitted to a journal next :

8/26/19
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
Company Submits Results of Clinical Trial for Publication in Peer Reviewed Medical Journal
https://ih.advfn.com/stock-market/USOTC/thera...unces-posi

then added into the Neutropenia market :

9/9/19
Therapeutic Solutions International Reports NanoStilbene™ Protects the Immune System
from Cancer Chemotherapy
Newly Discovered Properties of NanoStilbene Potentially Allows Company to Address
$3.9 Billion Chemotherapy Induced Neutropenia Market
https://ih.advfn.com/stock-market/USOTC/thera...rts-nanost


and into the anti-aging market next:

11/4/19
Therapeutic Solutions International Reports Augmentation of Rejuvenating Activity of Cord Blood Plasma by Pterostilbene
Company Expands Use of Commercially Available Anti-Inflammatory Nanoparticle Nutraceutical NanoStilbene™ into Anti-Aging Market
https://ih.advfn.com/stock-market/USOTC/thera...orts-augme

and NanoStilbene enters into an agreement to commercialize , and that's where we are w/ this product:

11/11/19
Therapeutics Solutions International Signs Agreement with Beijing Regenesis Biotechnology to License and Develop Patent for Anti-Aging use of Cord Blood Plasma and NanoStilbene
Company Expands Use of Commercially Available Anti-Inflammatory Nanoparticle Nutraceutical NanoStilbene™ into Anti-Aging Market
https://ih.advfn.com/stock-market/USOTC/thera...ns-agreeme